Molecular Templates share price today

(MTEM)

Molecular Templates share price is $0.01 & ₹0.86 as on 3 Jan 2025, 2.30 'hrs' IST

$0.01

▲

-0.03

(-67.5%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Molecular Templates share price in Dollar and Rupees. Guide to invest in Molecular Templates from India. Also see the sentimental analysis on Indian investors investing in Molecular Templates. Get details on the Indian mutual funds that are investing in Molecular Templates. Get Analyst recommendations and forecasts along with all the Molecular Templates's financials.

Molecular Templates share price movements

Today's Low: $0.01
Today's High: $0.04
$0.01
0.0%
Downside
Day's Volatility :75.61%
Upside
75.61%
52 Weeks Low: $0.01
52 Weeks High: $4.12
$0.01
0.0%
Downside
52 Weeks Volatility :99.76%
Upside
99.76%

Molecular Templates Returns

Period	Molecular Templates Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-97.26%	-10.0%	0.0%
6 Months	-96.64%	-4.7%	0.0%
1 Year	-98.84%	-0.9%	0.0%
3 Years	-99.93%	-2.4%	-21.2%

Molecular Templates Key Statistics

in dollars & INR

Previous Close	$0.04
Open	$0.03855
Today's High	$0.041
Today's Low	$0.01
Market Capitalization	$263.4K
Today's Volume	$4.3M
52 Week High	$4.12
52 Week Low	$0.01
Revenue TTM	$25.5M
EBITDA	$-13.9M
Earnings Per Share (EPS)	$-3.05
Profit Margin	-61.35%
Quarterly Earnings Growth YOY	-0.97%
Return On Equity TTM	-929.14%

How to invest in Molecular Templates from India?

It is very easy for Indian residents to invest directly in Molecular Templates from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Molecular Templates stock in both Indian Rupees (INR) and US Dollars (USD). Search for Molecular Templates or MTEM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Molecular Templates or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Molecular Templates shares which would translate to 85.740 fractional shares of Molecular Templates as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Molecular Templates, in just a few clicks!

Returns in Molecular Templates for Indian investors in Rupees

Investment Value

₹1,00,000

Molecular Templates investment value today

Current value as on today

₹3,265

Returns

₹96,735

(-96.74%)

Returns from Molecular Templates Stock

₹99,710 (-99.71%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Molecular Templates

12.56%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Investment in Molecular Templates from India has grown in the last 30 days as on Jan 3, 2025. 12.56% more purchase transactions for Molecular Templates in the last 30 days versus the previous period.

79%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Molecular Templates on INDmoney from India has grown in the last 30 days as on Jan 3, 2025. 79% more investors are searching Molecular Templates in the last 30 days versus the previous period.

Global Institutional Holdings in Molecular Templates

Bellevue Group AG
19.44%
SILVERARC CAPITAL MANAGEMENT, LLC
9.48%
Bvf Inc
7.93%
Bank of Montreal
1.11%
BMO Capital Markets Corp.
1.11%
Vanguard Group Inc
0.77%

Analyst Recommendation on Molecular Templates

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Molecular Templates(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Molecular Templates

What analysts predicted

Upside of 179900.0%

Current:

$0.01

Target:

$18.00

Insights on Molecular Templates

Price Movement
In the last 7 days, MTEM stock has moved down by -19.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 11.08M → 572.0K (in $), with an average decrease of 94.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 572.0K → -8.09M (in $), with an average decrease of 1515.6% per quarter
MTEM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 119.6%
MTEM vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 138.7%
Price to Sales
ForMTEM every $1 of sales, investors are willing to pay $0.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Molecular Templates Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.3M	↑ 202.45%
Net Income	$-30.3M	↑ 30.89%
Net Profit Margin	-415.86%	↑ 545.1%

	FY19	Y/Y Change
Revenue	$19.5M	↑ 167.73%
Net Income	$-69.5M	↑ 129.59%
Net Profit Margin	-356.62%	↑ 59.24%

	FY20	Y/Y Change
Revenue	$18.8M	↓ 3.35%
Net Income	$104.9M	↓ 250.88%
Net Profit Margin	556.73%	↑ 913.35%

	FY21	Y/Y Change
Revenue	$38.7M	↑ 105.34%
Net Income	$-79.3M	↓ 175.6%
Net Profit Margin	-204.96%	↓ 761.69%

	FY22	Y/Y Change
Revenue	$19.8M	↓ 48.95%
Net Income	$-92.7M	↑ 16.9%
Net Profit Margin	-469.36%	↓ 264.4%

	FY23	Y/Y Change
Revenue	$57.3M	↑ 190.1%
Net Income	$-8.1M	↓ 91.24%
Net Profit Margin	-14.18%	↑ 455.18%

	Q1 FY23	Q/Q Change
Revenue	$33.6M	↑ 1187.9%
Net Income	$8.5M	↓ 138.6%
Net Profit Margin	25.31%	↑ 869.78%

	Q2 FY23	Q/Q Change
Revenue	$6.6M	↓ 80.29%
Net Income	$-10.9M	↓ 227.71%
Net Profit Margin	-164.0%	↓ 189.31%

	Q3 FY23	Q/Q Change
Revenue	$6.8M	↑ 2.55%
Net Income	$4.2M	↓ 138.21%
Net Profit Margin	61.11%	↑ 225.11%

	Q4 FY23	Q/Q Change
Revenue	$7.0M	↑ 3.24%
Net Income	$-3.9M	↓ 195.06%
Net Profit Margin	-56.27%	↓ 117.38%

	Q1 FY24	Q/Q Change
Revenue	$11.1M	↑ 58.01%
Net Income	$572.0K	↓ 114.49%
Net Profit Margin	5.16%	↑ 61.43%

	Q2 FY24	Q/Q Change
Revenue	$572.0K	↓ 94.84%
Net Income	$-8.1M	↓ 1515.56%
Net Profit Margin	-1.4K%	↓ 1420.72%

	FY18	Y/Y Change
Profit	$-22.9M	↓ 1051.79%

	FY19	Y/Y Change
Profit	$-31.0M	↑ 35.35%

	FY20	Y/Y Change
Profit	$18.8M	↓ 160.75%

	FY21	Y/Y Change
Profit	$38.7M	↑ 105.34%

	FY22	Y/Y Change
Profit	$12.0M	↓ 69.11%

	FY23	Y/Y Change
Profit	$50.4M	↑ 321.57%

	Q1 FY23	Q/Q Change
Profit	$14.6M	↑ 2754.21%

	Q2 FY23	Q/Q Change
Profit	$-6.8M	↓ 146.53%

	Q3 FY23	Q/Q Change
Profit	$5.3M	↓ 178.04%

	Q4 FY23	Q/Q Change
Profit	$5.7M	↑ 8.27%

	Q1 FY24	Q/Q Change
Profit	$9.9M	↑ 73.26%

	Q2 FY24	Q/Q Change
Profit	$-4.8M	↓ 148.62%

	FY18	Y/Y Change
Operating Cash Flow	$-4.5M	↓ 68.7%
Investing Cash Flow	$-15.9M	↓ 264.13%
Financing Cash Flow	$49.2M	↓ 20.28%

	FY19	Y/Y Change
Operating Cash Flow	$-25.2M	↑ 465.38%
Investing Cash Flow	$-39.7M	↑ 149.13%
Financing Cash Flow	$65.7M	↑ 33.48%

	FY20	Y/Y Change
Operating Cash Flow	$-83.8M	↑ 231.95%
Investing Cash Flow	$-34.7M	↓ 12.74%
Financing Cash Flow	$58.9M	↓ 10.35%

	FY21	Y/Y Change
Operating Cash Flow	$-30.4M	↓ 63.74%
Investing Cash Flow	$-62.4M	↑ 80.13%
Financing Cash Flow	$92.6M	↑ 57.22%

	FY22	Y/Y Change
Operating Cash Flow	$-89.0M	↑ 192.97%
Investing Cash Flow	$95.3M	↓ 252.65%
Financing Cash Flow	$-265.0K	↓ 100.29%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-19.4M	↑ 5.04%
Investing Cash Flow	$26.0M	↓ 8.44%
Financing Cash Flow	$-27.5M	↑ 9936.5%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.6M	↓ 50.22%
Investing Cash Flow	$3.1M	↓ 87.92%
Financing Cash Flow	$-27.5M	↑ 0.0%

Molecular Templates Technicals Summary

Sell

Neutral

Buy

Molecular Templates is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Molecular Templates Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Molecular Templates Inc	-89.19%	-96.64%	-98.84%	-99.93%	-99.98%
Regeneron Pharmaceuticals, Inc.	-4.97%	-31.12%	-21.91%	15.48%	91.62%
Biontech Se	-1.42%	42.28%	6.01%	-49.15%	155.61%
Alnylam Pharmaceuticals, Inc.	-6.56%	-6.26%	22.36%	42.41%	102.91%
Vertex Pharmaceuticals Incorporated	-11.88%	-15.14%	-3.23%	81.51%	79.75%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Molecular Templates Inc	NA	NA	0.0	0.0	-9.29	-0.38	NA	1.08
Regeneron Pharmaceuticals, Inc.	17.61	17.61	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Molecular Templates Inc	Buy	$921.7K	-99.98%	NA	-61.35%
Regeneron Pharmaceuticals, Inc.	Buy	$78.3B	91.62%	17.61	33.61%
Biontech Se	Buy	$27.3B	155.61%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	102.91%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$103.7B	79.75%	32.84	-4.51%

About Molecular Templates

molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.

Organization	Molecular Templates
Employees	62
CEO	Dr. Eric E. Poma Ph.D.
Industry	Health Technology

Management People of Molecular Templates

Name	Title
Dr. Eric E. Poma Ph.D.	Interim CFO, Treasurer, Principal Acc. Officer, CEO, Chief Scientific Officer & Director
Ms. Jason S Kim	Consultant
Ms. Kristen Quigley B.A.	Chief Operating Officer
Dr. Grace Kim	Chief Strategy Officer & Head of IR
Dr. Michelle Iwamoto-Fan J.D., Ph.D.	Senior Vice President & General Counsel
Dr. Joseph Phillips Ph.D.	Senior VP & Head of CMC Development
Dr. Chris Moore Ph.D.	Senior VP and Head of Preclinical Development & Translational Medicine

Important FAQs about investing in Molecular Templates from India :

What is Molecular Templates share price today?

Molecular Templates share price today stands at $0.01, Open: $0.04 ; Previous Close: $0.04 ; High: $0.04 ; Low: $0.01 ; 52 Week High: $4.12 ; 52 Week Low: $0.01. The stock opens at $0.04, after a previous close of $0.04. The stock reached a daily high of $0.04 and a low of $0.01, with a 52-week high of $4.12 and a 52-week low of $0.01.

Can Indians buy Molecular Templates shares?

Yes, Indians can invest in the Molecular Templates (MTEM) from India.

With INDmoney, you can buy Molecular Templates at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Molecular Templates at zero transaction cost.

How can I buy Molecular Templates shares from India?

It is very easy to buy Molecular Templates from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Molecular Templates be purchased?

Yes, you can buy fractional shares of Molecular Templates with INDmoney app.

What are the documents required to start investing in Molecular Templates stocks?

To start investing in Molecular Templates, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.